org placeholder image

Mao Taketani

Director of Synthetic Biology at Jorna Therapeutics

  • LinkedIn

Email Email: m****@jornatx.com

phone noPhone Number: (***)-***-****

Passionate about utilizing synthetic biology to contribute to a healthier and more equitable world. Highly skilled in microbial genetic engineering and biochemistry but a generalist who c...

Read More

map
JORNA THERAPEUTICS

JORNA THERAPEUTICS

  • description Description
    Jorna is a Quantum Sky company. We use Quantum Skys AI to generate DNA/RNA editors, and apply them to develop previously unattainable treatments.
  • Employees count Employees 1-10
  • Revenue Revenue 1 Billion and Over
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Jorna Therapeutics Org Chart and Mapping

Employees

Mao Taketani

Director of Synthetic Biology

Vincent Digiacomo

Director, Therapeutic Innovation

Frequently Asked Questions Regarding Mao Taketani

Answer: Mao Taketani works for Jorna Therapeutics as Director of Synthetic Biology

Answer: Mao Taketani’s role in Jorna Therapeutics is Director of Synthetic Biology

Answer: Mao Taketani's email address is m***@gmail.com

Answer: Mao Taketani's business email address is m****@jornatx.com

Answer: Mao Taketani’s direct phone number is (***)-***-****

Answer: Mao Taketani works in the industry of: Biotechnology

Answer: Mao Taketani is the current Director of Synthetic Biology at Jorna Therapeutics.... Read More

Answer: Mao Taketani works Jorna Therapeutics located at 700 Main St, Cambridge, , 2139, Massachusetts, United States

Answer: Jorna Therapeutics's Director of Synthetic Biology is Mao Taketani

Answer: Mao Taketani contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@jornatx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access